AHA reiterates support for most-favored nation drug price rule’s withdrawal
The AHA today restated its strong support for the Centers for Medicare & Medicaid Services’ withdrawal of its Most Favored Nation Model proposed rule. In January, the AHA questioned the proposal’s legality and structure, while expressing deep concerns for the extent to which patients would be negatively impacted by the policy.
Related News Articles
Headline
Carmela Coyle, California Hospital Association president and CEO, announced plans Feb. 5 to retire in early 2027, according to the CHA. Coyle has been in…
Headline
The House Feb. 3 voted 217-214 to pass the government funding plan approved by the Senate Jan. 30, ending the four-day partial shutdown. Twenty-one Republicans…
Headline
The Department of Labor has issued a proposed rule to improve transparency of fees collected by pharmacy benefit managers. The rule requires PBMs to disclose…
Headline
The Senate has begun consideration of the appropriations package passed by the House Jan. 22, which contains conferenced legislation for the Departments of…
Headline
The AHA Jan. 28 released its 2026 Advocacy Agenda, containing the association’s key priorities for Congress, the administration, regulatory agencies and courts…
Headline
The Department of Health and Human Services Office of Inspector General Jan. 27 released a bulletin addressing how direct-to-consumer drug programs can sell…